LabCorp Extends Tender Offer for All Outstanding Shares of Orchid Cellmark Inc. Read more about LabCorp Extends Tender Offer for All Outstanding Shares of Orchid Cellmark Inc.
LabCorp is Scheduled to Present at the Credit Suisse 2011 Healthcare Conference Read more about LabCorp is Scheduled to Present at the Credit Suisse 2011 Healthcare Conference
Laboratory Corporation of America(R) Holdings Announces Third Quarter 2011 Results Read more about Laboratory Corporation of America(R) Holdings Announces Third Quarter 2011 Results
LabCorp Extends Tender Offer for All Outstanding Shares of Orchid Cellmark Inc. Read more about LabCorp Extends Tender Offer for All Outstanding Shares of Orchid Cellmark Inc.
Conversion Right Triggered for LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 Read more about Conversion Right Triggered for LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021
LabCorp To Offer a New Companion Diagnostic for Non-Small Cell Lung Cancer Read more about LabCorp To Offer a New Companion Diagnostic for Non-Small Cell Lung Cancer
LabCorp Extends Tender Offer for All Outstanding Shares of Orchid Cellmark Inc. Read more about LabCorp Extends Tender Offer for All Outstanding Shares of Orchid Cellmark Inc.
Laboratory Corporation of America(R) Holdings Announces Results of Offer to Purchase Its Zero Coupon Convertible Subordinated Notes Due 2021 Read more about Laboratory Corporation of America(R) Holdings Announces Results of Offer to Purchase Its Zero Coupon Convertible Subordinated Notes Due 2021
LabCorp to Offer a New Companion Diagnostic for Melanoma Read more about LabCorp to Offer a New Companion Diagnostic for Melanoma
LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest Read more about LabCorp's Zero Coupon Convertible Subordinated Notes Due 2021 to Accrue Contingent Interest
